欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号EE/H/0291/001
药品名称METFORAL XR
活性成分
    • metformin hydrochloride 500.0 mg
剂型Prolonged-release tablet
上市许可持有人Berlin-Chemie AG Glienicker Weg 125, Berlin 12489, Germany
参考成员国 - 产品名称Estonia (EE)
METFORAL XR
互认成员国 - 产品名称
    • Germany (DE)
      Siofor XR 500 mg Retardtabletten
    • Portugal (PT)
    • Poland (PL)
      Siofor XR 500 mg
    • Latvia (LV)
    • Lithuania (LT)
      Tivulin 500 mg pailginto atpalaidavimo tabletės
    • Hungary (HU)
      MEFORAL XR 500 mg retard tabletta
    • Bulgaria (BG)
      Siofor SR
    • Czechia (CZ)
      Siofor prolong 500 mg prolonged-release tablets
    • Romania (RO)
    • Slovakia (SK)
      Siofor SR 500 mg tablety s predĺženým uvoľňovaním
    • Slovenia (SI)
    • Croatia (HR)
      Siofor SR 500 mg tablete s produljenim oslobađanjem
许可日期2018/10/12
最近更新日期2024/03/13
药物ATC编码
    • A10BA02 metformin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase